FosB regulates expression of miR-22 during PMA induced differentiation of K562 cells to megakaryocytes
- PMID: 27889568
- DOI: 10.1016/j.biochi.2016.11.005
FosB regulates expression of miR-22 during PMA induced differentiation of K562 cells to megakaryocytes
Abstract
Expression of many miRNAs is altered in different cancers and these changes are thought to play a key role in formation and progression of cancer. In chronic myelogenous leukemia (CML) a number of miRNAs are known to be down regulated as compared to normal cells. In this report we have investigated the mechanism of this down regulation by using PMA induced differentiation of CML cell line K562 to megakaryocytes as an experimental system. On treatment with PMA, expression of many down regulated miRNAs including miR-22 is induced. PMA also induces expression of several transcription factors, including FosB, EGR1 and EGR2. Our results using a number of approaches, such as promoter reporter assay, FosB knock down and Chip assay, suggest that the expression of miR-22 is regulated transcriptionally by FosB.
Keywords: FosB; K562; PMA; miR-22.
Copyright © 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.
Similar articles
-
IsomiR processing during differentiation of myelogenous leukemic cell line K562 by phorbol ester PMA.Gene. 2018 Jan 30;641:172-179. doi: 10.1016/j.gene.2017.10.025. Epub 2017 Oct 17. Gene. 2018. PMID: 29051025
-
A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages.Biochim Biophys Acta. 2013 Aug;1833(8):1936-46. doi: 10.1016/j.bbamcr.2013.04.007. Epub 2013 Apr 17. Biochim Biophys Acta. 2013. PMID: 23602969
-
Regulation of megakaryocytic differentiation of K562 cells by FosB, a member of the Fos family of AP-1 transcription factors.Cell Mol Life Sci. 2009 Jun;66(11-12):1962-73. doi: 10.1007/s00018-009-8775-5. Cell Mol Life Sci. 2009. PMID: 19381435 Free PMC article.
-
BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.Oncogene. 2014 Jan 2;33(1):44-54. doi: 10.1038/onc.2012.557. Epub 2012 Dec 3. Oncogene. 2014. PMID: 23208504
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
Cited by
-
MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver.Cells. 2022 Sep 14;11(18):2860. doi: 10.3390/cells11182860. Cells. 2022. PMID: 36139435 Free PMC article.
-
Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy.Cell Death Dis. 2021 Feb 24;12(2):208. doi: 10.1038/s41419-021-03499-w. Cell Death Dis. 2021. PMID: 33627636 Free PMC article.
-
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.Elife. 2024 Apr 4;13:RP94765. doi: 10.7554/eLife.94765. Elife. 2024. PMID: 38573820 Free PMC article.
-
microRNA-22 promotes megakaryocyte differentiation through repression of its target, GFI1.Blood Adv. 2019 Jan 8;3(1):33-46. doi: 10.1182/bloodadvances.2018023804. Blood Adv. 2019. PMID: 30617215 Free PMC article.
-
Glucocorticoid receptor regulates expression of microRNA-22 and downstream signaling pathway in apoptosis of pancreatic acinar cells.World J Gastroenterol. 2018 Dec 7;24(45):5120-5130. doi: 10.3748/wjg.v24.i45.5120. World J Gastroenterol. 2018. PMID: 30568389 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous